Abstract
Purpose: This study investigates the validity, reliability, and detection limit of a visual examination method utilizing the Tyndall effect to enhance visible detection of particles. The suitability of the method for compatibility testing of intravenous fluids in a hospital pharmacy context is discussed.
Methods: A panel of 20 inspectors examined 20 samples, with and without particles, using two light sources (halogen lightbulb in a focused desk lamp and a red pocket laser pointer). The samples contained particles of different origin (precipitate, polystyrene standards), varying size, and concentrations. Light obscuration and turbidimetric measurements were used to obtain numeric references. The samples were divided into rejection probability zones, and the validity (sensitivity, specificity, and likelihood ratios) and reliability (inter-rater agreement coefficients Fleiss' kappa and Gwet's AC1) were estimated.
Results: The sensitivity of the laser pointer for detecting microprecipitates was quite high; however, it also showed a high false rejection rate. The specificity was slightly higher for the focused desk lamp than the laser pointer. The likelihood ratios were not within the recommended limits of a useful test, indicating that the method could not securely confirm the presence/absence of particles in the samples. The inter-rater agreement coefficients indicated fair to moderate agreement between the inspectors.
Conclusions: The validity and reliability were not satisfactory for either of the light sources. The visual detection limit seemed to be around 5 μm, although we propose that an exact detection limit is not that relevant for compatibility testing. Based on the current findings, the visual examination method cannot be recommended as the sole method for judging compatibility of parenteral nutrition and drugs, but rather in a program of several methods. In the hospital pharmacy, the method may be a resource, together with theoretical considerations, in situations where other methods are unavailable; however, use of in-line-filters is essential to protect the patient.
LAY ABSTRACT: Many patients under intensive care are in need of several intravenous drugs simultaneously. These drugs cannot be given in the same infusion line unless compatibility has been documented. Incompatibilities can result in, for example, precipitation of particles. Injected particles can harm the patient and should be avoided. Visual screening of blends of drugs for possible incompatibility, using a focused light source to enhance visual detection based on the Tyndall effect, could be a quick and easy methodology to identify incompatibility. In the following study the objective was to investigate how reliable visual inspection, with the utilization of the Tyndall effect, is at detecting particles and precipitations in blends of intravenous drugs and parenteral nutrition mixtures. Twenty inspectors each examined 20 different samples with two different light sources. Some of the samples were without particles (clean), and some contained different types and degrees of particle contamination. The inspectors' judgment of the samples was recorded and validity and reliability parameters were calculated to evaluate the method's suitability. The conclusion was that because of false positive and negative findings the visual inspection method alone is not enough to securely document compatibility/incompatibility, but it is more suitable as support together with additional methods.
- Sub-visual particles
- Total parenteral nutrition
- TPN
- Parenterals
- Inter-rater Reliability
- Incompatibility
- PocketLaser pointer
Introduction
Intravenous infusion of particles, especially in large number, represents a potentially life-threatening health risk (1). The full extent of clinical consequences of infusion of particles is still not clear (2), but among potential complications are the obstructions of vessels, formation of granuloma, and inflammatory and immunological responses (3⇓⇓–6). Particles with the size above the internal diameter of capillaries, which is on average 7 μm (7), are proposed to increase the risk of embolism (8). On the other hand, microthrombi associated with particles down to 2 μm have also been reported (3). Specific groups of patients might be more sensitive to the adverse effects of particles, and it has been proposed that neonates and young children are likely to be affected by lower amounts of particles compared to adults because of their lower density of the capillary bed and fewer pulmonary alveoli (2). Lehr and colleagues found that critically ill patients are more vulnerable to the effects of particles than healthy subjects (9). Particles of different sizes are distributed differently in the body according to animal studies: Particles of around 1 μm have been found in the liver, 3–6 μm particles have been found in the spleen and hepatic lymph nodes, and 10–12 μm particles have been found in the pulmonary capillaries (10). Even if the acute effects of infused particles might be rare, long-term effects, such as reduced organ function and tissue damage, could be a result of accumulated exposure to particles (10). Adverse effects caused by injected particles may also be underestimated because they could be confused with symptoms of the patient's underlying disease (10).
Intravenous fluids completely free from particles are not realistic, but measures should be made to minimize the amount of particles administered to patients. According to the harmonized European, U.S., and Japanese Pharmacopoeia, preparations intended for intravenous use should be inspected for visible particles (11⇓–13). Furthermore, limits for sub-visual particles are specified as follows: for large-volume parenterals (LVPs; >100 mL) no more than 25 particles/mL ≥10 μm and no more than 3 particles/mL ≥25 μm, and for small-volume parenterals (SVPs; <100 mL) no more than 6000 particles per container ≥10 μm and no more than 600 per container ≥25 μm as determined by light obscuration (14⇓–16).
Particles in a sterile product, other than gas bubbles, may consist of dust, glass, precipitate from drug incompatibility, rubber, cotton fibres, latex, or other insoluble materials; the sources of particle contamination can be the solution itself or its ingredients, packaging material, the production process, or the preparation of the product for administration (17, 18). Also, manipulation of the product after release from the manufacturer may introduce particles, for example, formation of microprecipitates due to drug incompatibility in Y-site administration of intravenous drugs (19).
Critically ill patients often need many intravenous preparations simultaneously, and a frequent problem is the lack of sufficient intravenous access sites to allow administration in separate lines. It is generally not recommended to give several drugs or drugs together with parenteral nutrition (PN; with or without lipids) in parallel infusion unless compatibility has been documented. PN admixtures are complex systems, with several constituents and considerable potential for physico-chemical interactions upon mixing with drugs (20). Calcium phosphate precipitations are a continuous concern for these blends (21)—in fact, deaths caused by obstruction of pulmonary microvasculature have been reported following the administration of three-in-one PN admixture (i.e., with lipids) containing calcium phosphate precipitate (1).
Questions regarding compatibility of intravenous drugs for Y-site administration are often directed to the hospital pharmacist, and the prospect to perform compatibility testing in the pharmacy without advanced analytical instruments has attracted attention (22, 23). There are two fundamental approaches to compatibility testing: static tests, where fixed concentrations are mixed in tubes (e.g., 22, 24, 25), and dynamic tests, where the actual administration system is modelled in the laboratory, for example, by Husson et al. (26). True infusion systems may result in concentration gradients, temperature gradients, and non-circulating fluid spaces, factors that are not addressed in static tests. In spite of their limitations, static tests add useful information (24, 25, 27). A static test utilizing the Tyndall effect to enhance the visibility of microprecipitates has been suggested as a simple and sensitive tool for evaluation of compatibility, in combination with theoretical considerations, in a hospital pharmacy setting (22, 23). This involves inspection of samples towards a black background using a strong focused light beam (Tyndall beam) directed at a right angle to the line of observation. Particles, if present, will scatter the light and the beam becomes visible through the sample (i.e., Tyndall effect), whereas in samples not containing particles (true solutions) the ray of light will be invisible. Small particles (≤1 μm) give rise to an opalescent reflection, whereas larger particles present themselves as twinkling separate spots in the Tyndall beam (23, 28). Use of a Tyndall beam to examine blends for precipitates is often described in Y-site compatibility testing literature (24, 25, 29, 30).
The visibility of particles, that is, the probability of detection during inspection, depends on factors like size, shape, density, and transparency of the particle, the location in the sample, as well as the light conditions and type of background used during inspection (18). Also, the number of particles in the container will affect the probability of their detection. The detection of particles is described as a probabilistic process (31), and different studies have indicated that the reliability of the results from visual examinations is only moderate (32⇓–34). However, none of these studies reported use of the Tyndall effect to enhance the visibility of sub-visual particles.
The overall aim of the current study was to investigate the validity and reliability of a visual examination method intended for compatibility testing between PN admixtures and intravenous drug solutions in our laboratory. Two different sources of focused light (Tyndall beams) were evaluated. The working hypothesis was that the Tyndall effect may be used to detect microprecipitates indicating incompatibility, but not to confirm compatibility. We also wanted to test if the method was sensitive enough to visually detect samples containing particle amounts close to or exceeding the Pharmacopoeial limits for sub-visual particles (see above), and specific enough not to give false-positive detection of particles. Therefore, the sub-goals were to identify the lower detection limit in terms of particle size, and to evaluate the robustness of the method with respect to who (the personnel) performs the examination. Finally, the suitability of the examination method for quick and easy compatibility testing of intravenous fluids in a hospital pharmacy setting should be addressed.
Materials and Methods
Materials
The 3-in-1 total parenteral nutrition (TPN) admixture was Olimel N5E (Baxter AS, Oslo, Norway), and the trace elements used was Tracel (Fresenius Kabi AS, Halden, Norway). Polystyrene microsphere size standards (EZY-CALTM Microsphere Size Standards, NIST Traceable Mean Diameter) of 2, 5, 10, 25, and 50 μm were from Thermo Scientific (Fremont, CA). Sodium hydroxide was from Sigma Aldrich (Seelze, Germany). All water was of Milli-Q quality (Millipore, Molsheim, France).
Sample Preparation
Clear, flat-bottom soda glass tubes of dimensions 100 × 24 × 0.9–1.0 mm (Scherf Präzision Europa GmbH, Meiningen, Germany) were used as sample containers. To provide particle-free, sterile containers, the tubes were sonicated for 15 min in a bath of Milli-Q water, rinsed with Milli-Q water, covered with washed aluminum foil, and subjected to dry sterilization (30 min at 180 °C). The samples were prepared in a laminar airflow safety cabinet using aseptic technique.
Because our main interest is in compatibility issues related to 3-in-1 admixtures, samples containing different amounts of calcium phosphate microprecipitates were prepared by addition of sodium hydroxide to induce precipitations from the aqueous phase of a TPN admixture. Hence, from a new, not-mixed, 3-in-1 TPN bag, the amino acid compartment and the glucose compartment were carefully extracted and mixed in right proportions in sterile vials. To avoid turbidity caused by oil droplets or surfactants, the fat compartment was replaced by Milli-Q water. Finally, trace elements were added. Vitamins were omitted because of the strong color that could interfere with the examination. From this mixture, referred to as TPNaq, samples of induced precipitation were prepared by addition of increasing amounts of 0.1 M sodium hydroxide. By making the pH of the solution more alkaline, more dibasic phosphate is formed, hence more of poorly soluble calcium monohydrogene phosphate precipitate (21).
Samples of known particle size and concentration were prepared from the polystyrene standards by dilution with Milli-Q-water. Clear controls, further referred to as particle-free samples, were prepared containing only Milli-Q water or the TPNaq. Milli-Q water, TPNaq and the sodium hydroxide solution were always filtered 0.22 μm (Pall, Ann Arbor, MI). All samples had a total volume of 10 mL.
After filling, the tubes were covered with Milli-Q-washed parafilm, and given a random three-digit number for use during examination. In total, 20 different samples were prepared (Table I).
Summary of Sample Contents and Results from the Turbidimetric Measurements, Light Obscuration Analysis, and Classification of Samples Based on Visual Examinations Conducted by the Inspectors
Examination Process
Two sources of focused light (Tyndall beams) were used; a highly focused beam obtained by a narrow-frequency red pocket laser pointer (630–650 nm, max output <1 mW) (Figure 1), and a wider beam of broad-frequency white light that illuminated the entire cross-section of the test tube (Figure 2). The latter was a desk lamp with a 75 watt halogen light bulb covered by an aluminum plate with an orifice of 1.5 cm diameter to focus the light as described by Veggeland and Brandl (22).
Detection of particles by the Tyndall effect using a red pocket laser pointer.
Inspection of sample with the focused light beam of a 75-watt halogen light bulb.
A panel of 20 inspectors, mostly pharmacists, with varying particle-screening experience, was recruited. Immediately before examination, the inspectors were given a short, individualized training in which they looked at examples of (i) clear, particle-free samples, (ii) samples containing calcium phosphate precipitation (highest concentration sample), and (iii) samples with polystyrene microspheres (10 μm). The samples were further available during the examination as references. The set of 20 samples were examined in a random order, first the whole set using the focused desk lamp and after a short break a second round using the laser pointer. The tubes were gently turned to set potential particles in motion and were studied in a vertical position over the focused light against a black background in a dark room. During examination the inspectors reported whether they observed signs of particles such as a continuous line or a haze in the samples (reject) or if they appeared to be clear and particle-free (accept). If the inspectors expressed uncertainty, the observation was interpreted as containing particles and rejected for the further analysis of data.
The visual examinations were conducted within 5 days. The precipitated samples were freshly mixed each day, and pH was measured. The polystyrene samples and the particle-free controls were prepared at the beginning of the experiment and stored at room temperature (22 ± 2 °C) and in the refrigerator (4–8 °C), respectively. The polystyrene samples were sonicated for 20 s prior to examination. The temperature during preparation, handling, and examination of all the samples was 22 ± 2 °C.
Particle Analysis
To measure the particle sizes and numbers in the samples, a light obscuration instrument (Accusizer 780 Optical Particle Sizer, Nicomp PSS, Santa Barbara, CA) was used. The sensor was model LE-400-05 with a particle size range of 0.5 to 400 μm (summation mode). The samples were measured undiluted to avoid dissolving precipitated particles, with a sample withdrawal of 5 mL. The precipitated samples were measured each day since they were freshly made, and the rest of the samples were measured at the end of the experiment. The results from the light obscuration analysis were used as a gold standard or numeric reference for the visual examination experiment. Also, the turbidity of the samples was measured as a second reference (2100Qis Turbidimeter, Hach Lange GmbH, Düsseldorf, Germany).
Analysis of Data
To classify the samples on basis of the examination results, the samples were divided into rejection probability zones (accept, grey, and reject zones) inspired by the methodology of Knapp and co-workers (31, 35). The rejection probability is the number of times the sample was judged as containing particles to the number of times the sample was examined. The reject zone consisted of samples with an overall rejection probability ≥70%, the grey zone included samples with rejection probability <70% and >30%, and the accept zone comprised the samples with rejection probability ≤30% (31, 35).
To estimate the validity of the examination method, and to compare the two light sources, the sensitivity, specificity, and likelihood ratios (LR+ and LR−) were calculated (36, 37) using MedCalc Software (Ostend, Belgium). Because estimation of prevalence is difficult when it comes to incompatibility, likelihood ratios were used instead of predictive values, as they are claimed to be less dependent on the prevalence (38). The LR+ ratio indicates how many times more likely a sample containing particles will be rejected compared to a sample not containing particles. At LR+ above 1 it is more likely that a sample containing particles will be rejected compared to a sample without particles, whereas LR+s below 1 means that a particle-free sample is more likely to be rejected (37). Correspondingly, the LR− ratio exhibit how many times more likely a sample with particles will be accepted compared to a sample not containing particles.
The reliability of the examination method was evaluated by calculation of the inter-rater reliability coefficients Fleiss' kappa (39) and Gwet's AC1 (40) using the software AgreeStat 2011.1 from Advanced analytics, LLC (Gaithersburg, MD). Both coefficients, ranging from 0 to 1 where 1 is perfect agreement, give an estimate of the extent of agreement between raters, here inspectors, adjusted for chance agreement. For interpretation, the scale of Landis and Koch was used as the benchmark (41).
The level of significance was set to 5 % for both the validity and reliability parameters.
Results and Discussion
Particle Analysis by Light Obscuration and Turbidimetric Measurements
The results from the light obscuration analysis and turbidimetric measurements are summarized in Table I. The particles counted in each sample were divided into size classes, where the lower class was 0.5–2 μm and the upper class was particles above 25 μm, the upper limit of the Pharmacopeia specification. As the samples could not be diluted because of the risk of dissolving precipitates, the particle content in some of the samples exceeded the recommended concentration range of the detector (9000 particles/mL), meaning that these counts should only be taken as a rough estimate.
All samples, except the controls (sample 1–4), contained a considerable amount of small particles (0.5–2 μm). Even though the smallest particles may perhaps not be the most dangerous ones, it is alerting because microprecipitate may, depending on the specific kinetics, grow (e.g., Ostwald ripening) or aggregate with time. The formation of microprecipitate does not necessarily progress in an identical manner each time, for example, the rate or time of onset can be affected by surrounding factors such as temperature. This emphasizes the need to study the compatibility over time and to have proper controls for comparison to be able to detect changes. In the case of Y-site infusion, the typical contact time between drug and TPN in the line is 15 to 60 min. It is also recommended to analyze the samples after mixing at a later time point, for example, after 4 h (25).
Samples with precipitated calcium phosphate (samples 5–10) showed a gradual increase in particle number with increasing pH value, as expected (Table I). The diluted polystyrene samples (samples 11–15) were found to contain the theoretical particle concentration of the particle size in question (marked with grey background in Table I) with only small deviations, whereas most of the high concentration samples (samples 16–20) generally indicated particle contents somewhat lower than the theoretical particle content. The latter might be due to aggregation of the particles. The high concentration samples were not diluted, which implies a high particle density and may contribute to aggregation. The particle standards are designed for single-use validation of particle counters' precision, and transferring the particle suspension to glass tubes for repeated examination and storage were outside the recommendations and might have influenced the quality. The resuspension method prior to use did not seem to break aggregates satisfactory, and therefore some inaccuracy was found in the measured particle content of undiluted samples. Table I also shows that it was not possible to avoid the presence of some particles both above and below the desired particle size for all polystyrene samples. This is consistent with the terms of the manufacturers' certificate of analysis, for example, for the 25 μm standard the certified mean diameter is 24.61 ± 0.22 μm and the approximate concentration is 2000 particles/ mL [(±10%) ≥ 15 μm]. Nevertheless, these standards were readily available, and because of their given concentration it was easy to dilute them to other concentrations. The particle-free controls (samples 1–4) showed low particle counts, although they contained a few particles, demonstrating that total freedom of particles is not an achievable goal.
The turbidimetric measurements confirmed a low turbidity of the particle-free controls. The precipitated samples showed a gradually increase in turbidity with increasing pH value, starting with a turbidity value similar to the controls (sample 5). The low-concentration polystyrene samples had overall very low turbidity values. The more concentrated samples showed higher turbidity values, but not as high as one might expect, considering that the particles were detectable also without utilizing a Tyndall beam. This indicates that the polystyrene particles transmit a lot of light. It has been suggested that a change in turbidity of 0.5 NTU as compared to the turbidity of the fluids before mixing may be defined as incompatibility (42). [FNU is equivalent to NTU in low regions, i.e., up to 40 NTU (43)]. Applying this limit, samples 6–10 and 17–20 would be regarded as incompatible or different as compared to the original, for example, the controls. Although it can be useful to define a limit like this, it is still important to evaluate and compare the result with the original solutions (controls) and look for overall changes.
Classification and Appearance of Samples by Visual Examination
The classification of samples, based on the inspectors' evaluations, is summarized in the rightmost side of Table I for both Tyndall beams. The six precipitated samples (samples 5–10) were all located in the reject zone (rejected by ≥70%) for examinations using the pocket laser pointer, whereas only the four samples with the highest pH (samples 7–10), that is, containing the highest amount of precipitate, were located in the reject zone using the focused desk lamp. The remaining two samples were found in the grey zone (rejected by <70% to >30%). Consulting the results from the particle analysis and turbidity measurements, this suggests that the laser pointer was quite sensitive in the detection of fine particles (<2 μm). Interestingly, more than 60% of the inspectors also reported identification of a Tyndall effect in the TPNaq controls (samples 1 and 2) with the laser pointer. Comparing the rejection rates with the results from the light obscuration and turbidimetric measurements, this finding may be regarded as false-positive. Also, in the wider light beam of the focused desk lamp, both TPNaq controls were classified in the grey zone, as 40–45% of the inspectors found the TPNaq controls to be different compared to the Milli-Q controls. The inspectors described the TPNaq controls as having a very weak bluish to white hint/opalescence compared to the clear, transparent appearance of Milli-Q water. Also, Trissel and co-workers commented that the PN solutions investigated with their Tyndall beam appeared as hazy liquids (24). The Tyndall effect observed in TPNaq samples seems to be an inherent property of the parenteral nutrient admixture. For instance, it is known that solutions containing fluorescent compounds can display a shaft of light similar to the Tyndall effect, when illuminated, and amino acids, which are part of TPN, can have this property (28). The authors have also experienced fluorescence with other drug solutions. This complicates the visual evaluation. It might also be other interactions between the components of the TPN admixture that contributes to the hazy appearance. The fact that the clear TPNaq controls were falsely rejected in the current study may be a warning that the laser pointer in particular may cause problems with too high frequency of false rejection in a compatibility test set-up involving complex mixtures. However, the Milli-Q controls were, as expected, found in the accept zone with both light sources. It is therefore plausible that the method is better suited for compatibility testing of simpler drug solutions without an inherent background noise, as described above for the TPNaq controls.
The appearance of the polystyrene particles was described as different from the calcium phosphate precipitate in both light sources. The polystyrene particles were more translucent and were sometimes mistaken for gas bubbles. The large polystyrene microspheres in low concentrations seemed to light up when illuminated with the laser pointer, but they were too few to form a continuous line. Because the laser beam was narrower than the width of the test tube and therefore less likely to hit and illuminate the particles, it was more difficult to detect particles at low concentrations. The wider beam of the focused desk lamp seemed somewhat better at identifying low numbers of larger particles. All high-concentration polystyrene samples (samples 16–20) were classified in the reject zone with both light sources, all with very high rejection rates. The high concentration of particulate matter (undiluted samples) was easily identified regardless of the actual size of the particles; they could also be recognized in normal light with the naked eye. Therefore, the diluted samples (samples 11–15) were more interesting. For these samples a higher rejection rate was found using the focused desk lamp compared to the laser pointer. It is interesting to notice that the sample with 2 μm microspheres 100/mL (sample 11) was accepted (30% rejection probability) with the laser pointer and found in the grey zone (35% rejection probability) with the focused desk lamp, whereas the 5 μm microspheres 50/mL was rejected by 50–55% of the inspectors. The larger microspheres (>5 μm) were mostly rejected by more than 50% of the inspectors (grey zone), regardless that the particle concentration was much lower. This suggests that the lower particle size limit for visual detection using a Tyndall beam is in the area around 5 μm, as also indicated by Veggeland and Brandl (22). Based on the findings, we propose that such a detection limit is primarily interesting for samples with a low number of particles—for instance, few precipitated crystals or other sources of particle contamination than incompatibility. In a sample with a high number of small particles, the use of a Tyndall beam will allow detection of even smaller particles, as the high number of particles scatters light sufficiently to be detected with the help of the Tyndall effect. This even applies to particles in the nanometer size range (e.g., samples 5 and 6).
The samples containing particles corresponding to the Pharmacopeia limits for sub-visual particles in LVPs, that is, 10 μm 25/mL (sample 13) and 25 μm 3/mL (sample 14), were rejected by 55–60% of the inspectors in the current study. This means that the inspectors were highly disagreeing on the evaluation, and that most of them would reject the sample as containing particles. This suggests that both sources of Tyndall beam could identify particles in this size and concentration range, but neither was robust enough to give consistent results in particle detection on the boarder of what is acceptable for sub-visual particles. The pharmacopeia limits are the only formal, numerical requirements regarding particle content of parenteral fluids, and are therefore interesting as comparison. It was easier to standardize samples with a particle content corresponding to the limits for LVPs because the limits are given per milliliter. SVPs have limits of total numbers per container. This results in different amounts of particles per milliliter. A SVP of 10 mL containing 6000 particles in total ≥10 μm would give a particle concentration of 600/mL ≥10 μm. Based on our findings, this would have been easier to detect than 25 particles/mL ≥10 μm. Therefore, the visual examination method using Tyndall beam might be more suitable for examination of SVPs as compared to LVPs. Nevertheless, it should be kept in mind that an increase in the number of small particles (sizes below of the Pharmacopoeia limits of 10 microns) is also relevant with respect to compatibility.
Validity and Reliability of the Examination Method
To further evaluate each of the light sources and compare its usability to the other, validity and reliability parameters were calculated (Table II and III, respectively). Generally, only small differences were found between the two light sources, and none of the differences were statistically significant. The specificity was slightly higher for the broad frequency white light of the focused desk lamp compared to the narrow frequency band of the red pocket laser pointer, suggesting that the focused desk lamp might be better at evaluating the negative samples correctly; that is, the negative samples were less frequently falsely rejected. Also, the LR+ was slightly higher for the focused desk lamp compared to the laser (Table II), again supporting the hypothesis that there is a lower possibility of a particle-free sample being rejected using this light source. The sensitivity was almost the same with both light sources. The LR+s were above 1, meaning that a sample containing particles is more likely to be rejected than a particle-free sample. To further understand the meaning of the size of the likelihood ratios, we conferred Jaeschke and colleagues' user guide (44): Likelihood ratios in the range 2 to 5, as estimated for both light sources, only give a small, but sometimes important, increase in the probability of the sample containing particles compared to the pre-test probability (i.e., the probability that the sample contains particles before the examination is performed). This can be interpreted as an indication that the method is only sometimes useful for its purpose. Higher LR+ values increases the power of the change, and LR+ values above 10 would be indicative of large, conclusive changes. The LR−s were estimated to be below 1 (Table II), meaning that a particle-free sample is more likely to be accepted than a particle containing sample. According to Jaeschke et al., negative likelihood ratios of 0.2–0.5 indicate only a small decrease in the probability of the sample containing particles compared to pre-test probability (44).
Comparison of the Ability To Identify Particles by Visual Examination Using the Two Different Light Sources (95% Confidence Interval), (LR = Likelihood Ratio)
Comparison of the Reliability of the Two Light Sources (95% Confidence Interval)
Regardless of the light source used, the inspectors expressed uncertainty during evaluation, most frequently with regard to the samples containing low concentrations of particles. Interfering factors, such as scratches on the glass walls and micro-bubbles in the samples, may also have confused the inspectors. More training and experienced inspectors could affect the outcome of this type of study.
Kappa statistics are frequently used to assess inter-rater agreement, but it is associated with weaknesses described as the kappa paradox (40). Gwet's AC1 was developed to overcome these challenges (40). Therefore, both inter-rater agreement coefficients were used in the analysis of reliability. Both the Fleiss' kappa and Gwet's AC1 were found to be somewhat higher for the laser pointer as compared to the focused desk lamp (Table III)—however, not on a statistically significant level. The 95% confidence intervals were rather wide. Based on the Landis and Koch scale, the AC1 values were interpreted as a moderate agreement between the inspectors using both light sources, whereas the Fleiss' kappa value indicated fair agreement for the focused desk lamp and moderate agreement for the laser (41). A fair to moderate agreement between the inspectors is not good enough to recommend this method alone for compatibility testing, as this means that the result would strongly depend on the inspector conducting the examination. Used in compatibility testing this could represent a risk of not detecting the incompatibility of two components that are in fact incompatible. However, scrutinizing the inter-rater agreement coefficients obtained for only the precipitated samples (more realistic samples) with the laser pointer, the inter-rater agreement factors increased; Gwet's AC1 of 0.83 (95% CI: 0.52–1). Therefore, it seems that the evaluations of the polystyrene samples caused the most disagreements and were responsible for pulling the inter-rater agreement down; the method could be better than the overall results imply. Even though polystyrene standard particles were easily available in the desired particle sizes and concentrations, they may appear different in examinations as compared to precipitated particles formed as a result of incompatibility.
In a patient safety perspective a false accept would have worse consequences than a false reject, and in the current study the false accepts were more associated with the (perhaps less relevant) low-concentration polystyrene samples. On the other hand, when using a test that gives many false rejects one might ask if the inspectors are rejecting the true-positive samples because they actually see particles or if they are guided by other features (e.g., background noise). If this feature was absent, would the true-positives still be rejected? For example, would precipitated samples without the background noise of TPN be rejected if they contained the same amount of particles? If no, the method could be less sensitive when applied to other sample sets.
Of note, there were more positive (particle-containing) than negative samples (particle-free) in the test set that the inspectors were examining, which may have caused imbalances in the results. A wide range of particle sizes as well as concentrations were investigated; nevertheless, more or different samples might give a different result. In future studies it might be interesting to include precipitates with a different appearance than calcium phosphate as well as more simple formulations than TPNaq. Because the examinations had to be conducted over several days in order to allow as many as 20 inspectors evaluating 20 samples, the samples were not identical at the time point for each of the visual examinations. The precipitated samples were freshly prepared each day, and due to the dynamics of precipitation the particle content and particle size in the samples could differ depending on whether they were examined early in the day or later. This was accounted for by analyzing samples before and after examinations, and some differences were observed (data not shown). Scrutinizing the evaluations given by the inspectors in detail, no clear tendency could be identified that corresponded to different evaluation of the samples depending on the time of the day they were examined (data not shown).
Other light sources, such as for instance cold fiber optic, might have some advantages over the ones investigated in this study. Possible advantages might be less heat generation and brighter light. The authors have performed some preliminary studies with a cold fiber optic light source and it seemed to provide a somewhat brighter picture of the samples, but the drawback was that the interfering factors were enhanced also. In other words, the inspector might still be confused and experience similar difficulties drawing a conclusion using more advanced light sources as well. In terms of the red pocket laser it can be argued that lasers with shorter wavelength, like blue or green lasers, and hence higher intensity light scattering would be more sensitive than the one used in the current study. The reason for choosing a red laser was that it was inexpensive and readily available, but also because such a laser had been used in another study discussing the Tyndall effect and particles in parenterals (22). Moreover, in preliminary studies we found that the green laser enhanced not only the particles of the samples, but also the background in particle-free samples; even in Milli-Q water a weak green line was detected. It was therefore regarded as plausible that using a shorter wavelength laser would increase the number of false-positives. This illustrates again the challenges of selecting the appropriate light source, but also the problems encountered when relying only on human vision to distinguish between the truly “bad” and “good” samples. Comparing the two tested light sources, it was found that the sensitivity of the narrow-band red light was approximately the same as for the broad-frequency white light, whereas the specificity of the red light was slightly lower (Table II).
Another aspect worth discussing when it comes to the design of compatibility studies is the method used to mix the samples. In the current study the mixing is done in test tubes with fixed concentrations, which represents a static compatibility test. It could also be possible to design a dynamic setup in order to achieve a more realistic simulation of drug meeting TPN in the infusion line. In real Y-infusion, different concentration gradients, temperature gradients, turbulence, and other events may occur and influence the mixing. These are all factors that are not easily simulated in a simplified static test.
Overall Discussion
Defining a specific size limit for particles considered harmful is challenging because the full extent of harmful effects of particles is not known. It is also complicated to define a limit to which particles can be considered visible because the detection of particles is dependent on several aspects in addition to size. Even small “sub-visual” particles might be detectable if they are large in number due to their combined light scattering. It has been suggested that the lower limit of visibility for the naked eye in normal light is around 40 μm (45), which may be lowered by the use of the Tyndall effect, possibly to a particle size around 5 μm (22); some reports claim even down to 1 μm (46). Our findings suggest that the lower detection limit for particles might be close to 5 μm. Nevertheless, defining a detection limit is probably more interesting for samples containing single or few particles. In compatibility testing it is important to detect changes occurring as a consequence of mixing (i.e., the evolution of particle growth and haze), which might begin with tiny particles increasing in number and size over time. Rather than focusing on the size limit, the suitable method should be able to detect indicators of change in mixed samples as compared to un-mixed controls. This can be equally challenging because the changes originating from incompatibilities are not always reproducible, as illustrated by Parikh and colleagues (8). They found calcium phosphate precipitation in a parenteral nutrient bag 30 h after compounding. The particles were detected by light obscuration, but could not be seen by visual examination using a “high-intensity lamp”. When they repeated the exact same experiment, even higher numbers of particles were counted in the light obscuration analysis, and this time the precipitation was also detected by visual examination. The experiment was apparently reproduced, but some factors beyond their control influenced the result, and the conclusion was different.
In a hospital pharmacy setting where access to advanced analytical instruments is limited, simple and inexpensive method like visual examinations seems attractive. It has been proposed that the visual method may have some advantages over electronic methods in cases were particles adhere to the container walls or when the particles are not evenly distributed in a sample (24). In the current study, the low-concentration polystyrene samples seemed more easily detected by visual examination than by turbidimetric measurements because the particles were translucent and gave only small changes in turbidity. However, the turbidimeter was sensitive in detecting changes from clear controls to increasingly precipitated samples. Other reports emphasize the benefit of an objective method for the detection of sub-visual precipitates, such as light obscuration, over the use of exclusively visual methods (21). Trissel and co-workers also draw attention to the fact that particle formation and turbidity may have been overlooked in some of the earlier compatibility studies with PN admixtures, as they did not evaluate sub-visual physical phenomena (24). Also, recent studies base the detection of particles entirely on visual detection, for example, screening for calcium phosphate precipitates in neonatal PN mixtures (47), but they do suggest using in-line filters as standard procedure to avoid injecting particles of risk. Nevertheless, the current study suggests that the validity and the reliability of the visual test are not good enough to ensure safety of the patients based entirely on this test alone. This is supported by Driscoll et al. (48) as well as the safety alerts regarding deaths following injection of calcium phosphate precipitates (1). It should be emphasized that in-line filters cannot replace proper compatibility testing, but they may be used as a secondary safety precaution to protect the patient.
Based on the findings of the current study, large particles and pronounced precipitations would be detected in visual examination with the Tyndall beam, but when the particles were smaller in size and/or in lower concentrations the inspectors expressed a considerable degree of uncertainty and the inter-rater agreement decreased. Our results suggest that the method is not optimal as a single method for compatibility screening for the purpose of parallel infusion of PN and drugs. If precipitation is observed, the method can offer support to advise against parallel infusion. However, lack of detected particles/precipitates cannot be interpreted as clear evidence of no compatibility problem for the respective products. Thus, we conclude that the complex issue of compatibility should be based on careful evaluation of data founded on more than just one visual examination. No method alone is without weaknesses, instrumental methods being no exception. Therefore, a program of several methods evaluating different indicators of incompatibility and providing a broad basis for evaluation of compatibility issues is recommended. Visual examination may serve as one of the methods in a screening program (27, 30). In a critical situation where no documentation is available and a more extensive analysis, including instrumental methods, is not accessible, the visual examination method using a Tyndall beam to enhance the visibility of sub-visible particles may serve as a resource (20). Using an in-line filter is paramount as a secondary safety precaution to protect the patient (48).
To increase safety in clinical practice, research labs and the pharmaceutical industry should have a continuous focus on compatibility testing to provide quality-controlled documentation on compatibility.
Conclusions
A panel of 20 inspectors applied two sources of focused light (Tyndall beams) in the examination of 20 samples with different particle content; a highly focused beam obtained from a red pocket laser pointer, and a wider beam illuminating the entire cross-section of the test tube obtained with a focused desk lamp. The validity (sensitivity, specificity, and likelihood ratios), and especially the reliability (inter-rater agreement), were not found satisfactory using either of the light sources to enhance the visibility of sub-visual particles. There were no significant differences between the two light sources, although the laser pointer might be better fitted for the detection of microprecipitate, whereas the focused desk lamp is perhaps more suitable for identification of larger particles in low concentrations. The findings suggest that the lower detection limit for particles might be around 5 μm, although we propose that such a detection limit is not that relevant for compatibility testing.
Based on the findings of the current study, the visual examination method cannot be recommended as the sole method for judging compatibility of PN admixtures and drugs, but should rather serve as one of several methods in a screening program. The Tyndall effect may be used to detect microprecipitates indicating incompatibility, but not to confirm compatibility. In a hospital pharmacy setting, the method may be a resource, together with theoretical considerations, in situations where other methods are unavailable; however, use of an in-line filter is recommended as a secondary safety precaution to protect the patient.
Conflict of Interest Declaration
The authors declare that they have no conflicting interests.
Acknowledgements
Vigdis Staven is a PhD-student of Hospital Pharmacy of North Norway Trust (Tromsø, Norway), and Department of Pharmacy, University of Tromsø (Norway), sponsored by Helse Nord RHF. We gratefully acknowledge the financial support from the Norwegian Medicines for Children Network (Bergen, Norway). Our gratitude goes also to Frode Skjold, Department of Pharmacy, University of Tromsø, for valuable discussions on the statistical issues, to Margaret Aarag Antonsen, Hospital Pharmacy of North Norway Trust, and the employees of the Hospital Pharmacy of Tromsø (Norway), for discussions, help, and practical support. Last but not least, we would like to express our gratitude to all the inspectors who participated in the study.
- © PDA, Inc. 2015